SaOS-2 is a retinoblastoma-associated gene (RB1)-null and TP53-null cell line derived from an osteosarcoma tumor treated with RTG, methotrexate, adriamycin, vincristine, cytoxan, and aramycin-C from an 11 year-old female [25]. The gene discussed is TP53; the disease is osteosarcoma.